CIK: 0001281446 · Show all filings
Period: Q2 2016 (← Previous) (Next →)
Filing Date: Aug 15, 2016
Total Value ($000): $349,225 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | ADAMAS PHARMACEUTICALS INC | 2,109,099 | $31,932 | 9.1% | $18.75 | — | COM | 00548A106 |
| VNDA | VANDA PHARMACEUTICALS INC | 2,705,758 | $30,277 | 8.7% | $10.50 | -7.7% | COM | 921659108 |
| — | SYNERGY PHARMACEUTICALS DEL | 7,590,000 | $28,842 | 8.3% | $4.49 | — | COM NEW | 871639308 |
| EXEL | EXELIXIS INC | 3,200,000 | $24,992 | 7.2% | $4.88 | +18.1% | COM | 30161Q104 |
| — | DERMIRA INC | 800,000 | $23,400 | 6.7% | $29.25 | — | COM | 24983L104 |
| — | BLUEBIRD BIO INC | 500,000 | $21,645 | 6.2% | $42.67 | — | COM | 09609G100 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 470,000 | $21,362 | 6.1% | $41.64 | +10.6% | COM | 64125C109 |
| EGRX | EAGLE PHARMACEUTICALS INC | 548,290 | $21,268 | 6.1% | $41.64 | 0.0% | COM | 269796108 |
| — | ZOGENIX INC | 2,440,959 | $19,650 | 5.6% | $11.56 | — | COM NEW | 98978L204 |
| — | IGNYTA INC | 3,238,703 | $17,554 | 5.0% | $5.54 | — | COM | 451731103 |
| ENTA | ENANTA PHARMACEUTICALS INC | 538,024 | $11,863 | 3.4% | $26.18 | 0.0% | COM | 29251M106 |
| — | SAGE THERAPEUTICS INC | 330,000 | $9,943 | 2.8% | $30.13 | — | COM | 78667J108 |
| — | TETRAPHASE PHARMACEUTICALS I | 2,299,529 | $9,888 | 2.8% | $6.71 | — | COM | 88165N105 |
| — | CONNECTURE INC | 4,127,232 | $9,328 | 2.7% | $9.01 | — | COM | 20786J106 |
| XNCR | XENCOR INC | 450,000 | $8,546 | 2.4% | $11.83 | +15.9% | COM | 98401F105 |
| AUPH | AURINIA PHARMACEUTICALS INC | 2,457,144 | $7,192 | 2.1% | $3.52 | -22.5% | COM | 05156V102 |
| — | ALCOBRA LTD | 1,414,573 | $6,351 | 1.8% | $5.99 | — | SHS | M2239P109 |
| — | RAPTOR PHARMACEUTICAL CORP | 978,350 | $5,254 | 1.5% | $5.98 | — | COM | 75382F106 |
| SRPT | SAREPTA THERAPEUTICS INC | 238,900 | $4,556 | 1.3% | — | — | Call | 803607100 |
| — | SUNESIS PHARMACEUTICALS INC | 8,173,937 | $4,477 | 1.3% | $1.47 | — | COM NEW | 867328601 |
| — | BOVIE MEDICAL CORP | 2,680,000 | $4,395 | 1.3% | $2.72 | — | COM | 10211F100 |
| — | ARADIGM CORP | 1,002,962 | $4,383 | 1.3% | $8.85 | — | COM NO PAR NEW | 038505400 |
| — | INTRA CELLULAR THERAPIES INC | 100,000 | $3,882 | 1.1% | $38.82 | — | COM | 46116X101 |
| — | OCERA THERAPEUTICS INC | 1,963,777 | $3,731 | 1.1% | $6.20 | — | COM | 67552A108 |
| — | SERES THERAPEUTICS INC | 120,000 | $3,486 | 1.0% | — | — | Put | 81750R102 |
| — | TENAX THERAPEUTICS INC | 1,108,593 | $2,838 | 0.8% | $3.93 | — | COM | 88032L100 |
| — | FOAMIX PHARMACEUTICALS LTD | 274,756 | $1,745 | 0.5% | $6.35 | — | SHS | M46135105 |
| — | ADVERUM BIOTECHNOLOGIES INC | 550,116 | $1,738 | 0.5% | $3.16 | — | COM | 00773U108 |
| ASND | ASCENDIS PHARMA A S | 76,511 | $1,015 | 0.3% | $13.27 | — | SPONSORED ADR | 04351P101 |
| — | CALADRIUS BIOSCIENCES INC | 1,525,244 | $900 | 0.3% | $1.87 | — | COM | 128058104 |
| — | DIPEXIUM PHARMACEUTICALS INC | 87,914 | $871 | 0.2% | $9.91 | — | COM | 25456J104 |
| VCEL | VERICEL CORP | 253,502 | $570 | 0.2% | $2.85 | +1.3% | COM | 92346J108 |
| — | PARATEK PHARMACEUTICALS INC | 29,266 | $407 | 0.1% | $25.19 | — | COM | 699374302 |
| — | AXOVANT SCIENCES LTD | 25,000 | $321 | 0.1% | $12.84 | — | COM | G0750W104 |
| — | REVANCE THERAPEUTICS INC | 21,665 | $295 | 0.1% | $13.62 | — | COM | 761330109 |
| — | STREAMLINE HEALTH SOLUTIONS | 151,611 | $182 | 0.1% | $6.45 | — | COM | 86323X106 |
| — | RIGEL PHARMACEUTICALS INC | 50,000 | $112 | 0.0% | $2.08 | — | COM NEW | 766559603 |
| ARDX | ARDELYX INC | 3,444 | $30 | 0.0% | $8.17 | 0.0% | COM | 039697107 |
| — | AMARIN CORP PLC | 2,000 | $4 | 0.0% | $2.00 | — | SPON ADR NEW | 023111206 |